U.S. Markets close in 5 mins

PLx Pharma Inc. (PLXP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.80+0.09 (+0.93%)
As of 4:00PM EDT. Market open.

PLx Pharma Inc.

9 Fishers Lane
Suite E
Sparta, NJ 07871
United States
973 409 6541
http://plxpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees8

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael J. ValentinoExec. Chairman353.12kN/A1954
Ms. Natasha GiordanoCEO, Pres & Director749.75kN/A1960
Ms. Rita M. O'Connor C.P.A., CPACFO and Head of Manufacturing & Supply Chain552.92kN/A1968
Mr. Ronald R. ZimmermanFounder & Sr. AdvisorN/AN/A1953
Mr. Tom LongVP of Manufacturing & Technical OperationsN/AN/AN/A
Ms. Joanne CotignolaVP of MarketingN/AN/AN/A
Mr. Patrick M. LonerganMember of Chief Exec. Officer Advisory GroupN/AN/A1935
Mr. Charles Edmund Sheedy C.F.A., CFAMember of Chief Exec. Officer Advisory GroupN/AN/A1947
Mr. Harris Kaplan MBAMember of Chief Exec. Officer Advisory GroupN/AN/A1952
Mr. Gary L. MossmanSr. AdvisorN/AN/A1941
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.

Corporate Governance

PLx Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.